In man amiloride hydrochloride has been shown to be an orally effective diuretic which causes a positive potassium balance. It also enhances the saluretic effects of hydrochlorothiazide and ethacrynic acid and in addition prevents the negative potassium balance caused by these diuretics (Wilson et al., 1966; Gombos et al., 1966 Control readings are the average for all cases for the second outpatient visit. Treatment averages include the three-and six-week readings for all patients.
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J. W. PATERSON,* M.B., B.SC., M.R.C.P.; C. T. DOLLERY, M.B., B.SC., M.R.C.P. RUTH M. HASLAM4t M.B., M.R.C.S., D.C.P., M.C.PATH. Brit. med.J., 1968, 1, 422-423 In man amiloride hydrochloride has been shown to be an orally effective diuretic which causes a positive potassium balance. It also enhances the saluretic effects of hydrochlorothiazide and ethacrynic acid and in addition prevents the negative potassium balance caused by these diuretics (Wilson et al., 1966; Gombos et al., 1966) . Gombos et al. also studied its effects in 10 hypertensive patients, all of whom were on other antihypertensive agents. The present study was undertaken to compare the effect of amiloride hydrochloride with hydrochlorothiazide in mild hypertensives who were on no other therapy.
Patients and Methods
Previously untreated hypertensive outpatients whose systolic blood pressure was not greater than 250 mm. Hg and diastolic blood pressure not greater than 130 mm. Hg were selected. Patients with heart failure, grade 3-4 retinopathy, or a blood urea greater than 60 mg./100 ml. were There was no significant difference between the average blood urea in the pretreatment period (31 mg./100 ml.) and the average blood urea when either amiloride alone (32 mg./100 ml.) or hydrochlorothiazide (33 mg./100 ml.) was given. However, on the combined diuretic regimen the average blood urea rose significantly to 40 mg./100 ml. as compared with the pretreatment value (P=0.013). The average plasma potassium was signicantly higher (P= 0.011) on amiloride (4.6 mEq/l.) than before treatment (4.2 mEq/l.). However, no individual value was higher than the upper limit of the normal range, and the highest value recorded was 5.1 mEq/l. On hydrochlorothiazide the average plasma potassium fell to 3.7 mEq/l., which was significantly less than control (P=0.016), and in addition three individual values were below the lower limit of normal (3.0, 3.1, 3.1 mEq/l.). On the combined regimen the average value (4.0 mEq/l.) was not significantly different from that before treatment; only one reading was below normal (3.7 mEq/l.) and the highest value was 4.3 mEq/1. Table II . No abnormality of haemoglobin, white cell count, or urine was seen on any treatment regimen.
The combination of a potassium-sparing diuretic such as amiloride or triamterene with a thiazide promises to be a satisfactory way of avoiding hypokalaemia in patients who require long-term diuretic therapy. It may also be dangerous because of the risk of hyperkalaemia. This may occur if potassium supplements are continued after a potassium-sparing diuretic is started, and has also been reported when these drugs are used alone. The risk of hyperkalaemia is increased in the presence of renal impairment. Cohen (1966) reported a rise in average serum potassium in 10 elderly men with congestive heart failure who were treated with a combination of 100 mg. of triamterene and 0.5 g. of chlorothiazide. In five patients the serum potassium rose above 6 mEq/l. In addition he reported the death of two patients in whom hyperkalaemia induced by a mixture of triamterene and hydrochlorothiazide was thought to have contributed. Deaths have also been reported due to hyperkalaemia with spironolactone (Sjoberg and Kreisle, 1962) .
The potency of the diuretic combination demands care in the choice of dose to avoid excessive salt loss, as occurred in two patients in this study. This disadvantage could probably be overcome by using smaller doses of each agent.
Though amiloride reduces serum uric acid when given alone it does not prevent the hyperuricaemia caused by thiazides. Cranston et al. (1963) , who compared the effects of bendrofluazide, cyclopenthiazide, and chlorthalidone in hypertensive patients.
Our results compare with those of Gombos et al. (1966) , who studied the effects of amiloride and hydrochlorothiazide in 10 hypertensives who were already on other antihypertensive drugs. They found no significant difference between the hypotensive effect of amiloride, hydrochlorothiazide, or the two drugs in combination. There was no significant difference in body weight on the three regimens and biochemical changes were similar to those seen in the present study.
Summary
The hypotensive effect of amiloride hydrochloride (MK-870) was investigated in mild hypertensive patients by means of a crossover trial comparing the effects of amiloride (15 mg. daily), hydrochlorothiazide (50 mg. daily), and amiloride (15 mg. daily) + hydrochlorothiazide (50 mg. daily). Amiloride was found to have a mild non-postural hypotensive effect indistinguishable from that of hydrochlorothiazide. The combination of the two agents produced no further hypotensive effect. This particular combination of the agents was thought to be too potent, as two patients had to withdraw owing to excessive diuresis and the average blood urea rose significantly while on the two diuretics. However, it was noted that when the two agents were combined the plasma potassium remained near pretreatment levels, whereas with hydrochlorothiazide alone the plasma potassium tended to fall and on amiloride alone it rose.
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